A New Era of Accessible Health Monitoring GARDEN GROVE, CALIFORNIA / ACCESS Newswire / June 9, 2025 / JBA AI, the flagship ...

Independent Global Study Evaluates EHR Satisfaction Across 110 Countries; 93% of European Users Say Dedalus Clinical ...

The female stress urinary incontinence treatment device market is projected to be worth USD 770.0 million in 2024. The market is anticipated to reach USD 1,432.0 million by 2034. The market is further ...

The HIV/HBV/HCV test kits market plays a vital role in the global fight against infectious diseases. These diagnostic tools are crucial for early detection and effective treatment of HIV, hepatitis B ...

Nucleic acid isolation and purification sales across the globe are estimated to be USD 1,178.6 million in 2025 and USD 2,038.1 million in 2035. Sales CAGR during the period of 2025 to 2035 is ...

The global surgical booms market size is estimated to be worth USD 317.1 million in 2025 and anticipated to reach a value of USD 477.7 million by 2035. Sales are projected to rise at a CAGR of 4.3% ...

The global Clinical Trials market is valued at USD 126.4 billion in 2025 and is projected to reach USD 192.6 billion by 2035, growing at a steady 4.3% CAGR. Demand is being driven by the resurgence of ...

The global sales of small bore connectors market is estimated to be worth USD 633.1 million in 2025 and anticipated to reach a value of USD 924.8 million by 2035. Sales are projected to rise at a CAGR ...

Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season  Paris, June 9, 2025. Sanofi is shipping Beyfortus (nirsevimab) starting in early ...

Domino Printing Sciences Reveals Carbon Reduction Plan with Target to Reach Net Zero by 2050 Domino Printing Sciences (Domino) has announced its commitment to reducing emissions with a view to ...

Landmark study reveals survival limits of kidney transplantation in older and high-risk patients (Vienna, Austria, Thursday 5 June 2025) A major international study, being presented today at the 62nd ...

AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technologyThird asset to advance into clinical trials, validating broad potential of ...